During the Covid-19 pandemic, in fact, patients with cancer are subject to multiple risks. First of all, they are more likely to get infected due to their immunosuppressed state related to the tumor disease or anticancer treatment they are receiving. Secondly, because of the usual hospital-centric management, they are often called to go to the hospital for treatment, diagnostic investigations and for follow-up. Thirdly, when they contract Covid-19 disease their clinical course is more likely to be severe.
Covid-19 and cancer patients: Choosing wisely is the key
Renato Cannizzaro
Conceptualization
;
2020-01-01
Abstract
During the Covid-19 pandemic, in fact, patients with cancer are subject to multiple risks. First of all, they are more likely to get infected due to their immunosuppressed state related to the tumor disease or anticancer treatment they are receiving. Secondly, because of the usual hospital-centric management, they are often called to go to the hospital for treatment, diagnostic investigations and for follow-up. Thirdly, when they contract Covid-19 disease their clinical course is more likely to be severe.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Covid e cancro.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
265.33 kB
Formato
Adobe PDF
|
265.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
Covid+e+cancro-Post_print.pdf
Open Access dal 09/04/2021
Tipologia:
Bozza finale post-referaggio (post-print)
Licenza:
Creative commons
Dimensione
657.09 kB
Formato
Adobe PDF
|
657.09 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
